Cedars-Sinai Medical Center
The assay combines microfluidics, gene expression, and digital PCR to provide information on whether a patient's cancer has metastasized.
The privately held company is coupling gene expression tests with analysis to produce clinical decision support as it expands beyond its historic focus on pharma.
Investigators See Future for NanoVelcro Cell Technology in Diagnosis of Pregnancy Complications
Premium
Researchers demonstrated that detection of single and clustered circulating trophoblasts could reliably differentiate placenta accreta from normal controls and other disorders, even early in gestation.
Cedars-Sinai Medical Center, One Health Laboratories Nab EUAs for Coronavirus Tests
The Cedars-Sinai Medical Center SARS-CoV-2 RT-PCR assay uses the A*Star Fortitude Kit 2.0 for the detection of SAR-CoV-2 specific RNA in nasopharyngeal swab samples.
Companies in the AMR space have met resistance from investors and clinicians as a result of conflicting hospital priorities and perceived technology shortcomings.